Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · Real-Time Price · USD

618.43

+9.89 (1.63%)

At close: Sep 3, 2026, 4:00 PM EDT

619.89

+1.46 (0.24%)

After-hours: Sep 3, 2026, 7:45 PM EDT

Thermo Fisher Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	228,663	217,704	198,988	205,083	216,998	262,925
Market Cap Growth	22.90%	9.41%	-2.97%	-5.49%	-17.47%	42.43%
Enterprise Value	267,148	249,974	227,963	234,504	243,417	272,609
Last Close Price	618.43	578.30	517.37	526.44	544.71	658.54

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	33.28	32.47	31.41	34.21	31.22	34.04
Forward PE	23.56	24.05	22.87	24.65	25.00	32.55
PS Ratio	4.93	4.89	4.64	4.79	4.83	6.71
PB Ratio	4.34	4.07	4.01	4.38	4.92	6.42
P/FCF Ratio	31.25	34.60	27.38	29.61	31.40	38.73
P/OCF Ratio	25.37	27.85	22.96	24.40	23.71	28.24
PEG Ratio	2.61	3.13	2.76	2.51	1.17	1.91

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.77	5.61	5.32	5.47	5.42	6.95
EV/EBITDA Ratio	22.76	22.44	21.04	21.86	20.39	21.03
EV/EBIT Ratio	30.37	29.91	29.50	32.03	28.44	26.28
EV/FCF Ratio	36.51	39.72	31.37	33.85	35.22	40.15

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.81	0.76	0.66	0.78	0.82	0.89
Debt / EBITDA Ratio	3.48	3.51	2.90	3.28	2.92	2.74
Debt / FCF Ratio	5.81	6.49	4.51	5.30	5.23	5.35
Net Debt / Equity Ratio	0.73	0.57	0.55	0.61	0.63	0.78
Net Debt / EBITDA Ratio	3.28	2.76	2.51	2.67	2.31	2.46
Net Debt / FCF Ratio	5.26	4.89	3.74	4.13	4.00	4.69
Asset Turnover	0.43	0.43	0.44	0.44	0.47	0.48
Inventory Turnover	4.89	5.05	4.99	4.81	4.86	4.31
Quick Ratio	1.01	1.36	1.14	1.27	1.06	1.00
Current Ratio	1.55	1.89	1.66	1.76	1.48	1.50
Return on Equity (ROE)	13.51%	13.02%	13.13%	13.09%	16.35%	20.47%
Return on Assets (ROA)	5.13%	5.03%	4.93%	4.67%	5.56%	7.90%
Return on Invested Capital (ROIC)	8.84%	9.59%	9.19%	9.49%	10.75%	15.17%
Return on Capital Employed (ROCE)	9.00%	8.80%	9.20%	8.60%	10.70%	12.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.05%	3.08%	3.18%	2.92%	3.20%	2.94%
FCF Yield	3.20%	2.89%	3.65%	3.38%	3.19%	2.58%
Dividend Yield	0.30%	0.30%	0.30%	0.27%	0.22%	0.16%
Payout Ratio	10.12%	9.49%	9.20%	8.72%	6.55%	5.11%
Buyback Yield / Dilution	1.44%	1.31%	1.29%	1.52%	0.76%	0.50%
Total Shareholder Return	1.75%	1.60%	1.59%	1.79%	0.98%	0.66%

SEC Filings: 10-K · 10-Q